Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 11-May-23 8:51 PM View:  | Acelyrin, Inc. (SLRN) | 09-May-23 | Purchase | 5,556 | $18.00 | $100,008.00 | 100% 0 to 5.56K | |
| 11-May-23 8:51 PM View: | Acelyrin, Inc. (SLRN) | 09-May-23 | Purchase | 1,750 | $18.00 | $31,500.00 | 31% 5.56K to 7.31K | |
| 17-Oct-22 6:49 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 14-Oct-22 | Sale (Planned) | 1,629 | $40.16 | $65,420.60 | (2%) 68.32K to 66.69K | |
| 14-Oct-22 12:58 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 12-Oct-22 | Sale | 3,484 | $38.22 | $133,158.00 | (5%) 71.81K to 68.32K | |
| 19-Sep-22 9:39 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 16-Sep-22 | Grant | 20,000 | -- | -- | 39% 51.81K to 71.81K | |
| 03-Mar-22 6:12 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 03-Mar-22 | Sale (Planned) | 420 | $64.55 | $27,111.00 | (< 1%) 52.23K to 51.81K | |
| 03-Mar-22 6:12 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-22 | Grant | 14,000 | -- | -- | 36% 38.76K to 52.76K | |
| 03-Mar-22 6:12 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-22 | Sale | 534 | $66.62 | $35,575.10 | (1%) 52.76K to 52.23K | |
| 14-Oct-21 6:33 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 14-Oct-21 | Market Sale (Planned) | 3,261 | $81.16 | $264,663.00 | (8%) 42.02K to 38.76K | < 1% |
| 14-Oct-21 6:33 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 12-Oct-21 | Market Sale | 3,477 | $82.79 | $287,861.00 | (8%) 45.5K to 42.02K | 2% |
| 04-Jun-21 4:13 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 02-Jun-21 | Grant | 5,000 | -- | -- | 100% 5.0K to 10.0K | |
| 03-Mar-21 8:38 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-21 | Grant | 5,500 | -- | -- | 14% 40.0K to 45.5K | |
| 13-Oct-20 5:52 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 12-Oct-20 | Grant | 40,000 | -- | -- | 100% 0 to 40.0K | |
| 29-Sep-20 8:09 PM View: | Prelude Therapeutics Inc (PRLD) | 29-Sep-20 | Purchase | 10,000 | $19.00 | $190,000.00 | 100% 0 to 10.0K | |
| 02-Jul-20 4:25 PM View: | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 39,573 | $18.00 | $712,314.00 | (100%) 39.57K to 0 | |
| 02-Jul-20 4:25 PM View: | Portola Pharmaceuticals Inc (PTLA) | 18-Jun-20 | Grant | 10 | $8.36 | $83.60 | 100% 0 to 10 | |
| 05-Jun-20 6:09 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 03-Jun-20 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 03-Mar-20 6:51 PM View: | Portola Pharmaceuticals Inc (PTLA) | 02-Mar-20 | Payment of Exercise | 4,543 | $9.68 | $43,976.20 | (5%) 82.77K to 78.23K | |
| 04-Feb-20 6:51 PM View: | Portola Pharmaceuticals Inc (PTLA) | 03-Feb-20 | Payment of Exercise | 3,435 | $12.89 | $44,277.20 | (4%) 84.97K to 81.53K | |
| 04-Feb-20 6:51 PM View: | Portola Pharmaceuticals Inc (PTLA) | 31-Jan-20 | Grant | 16,250 | -- | -- | 24% 68.72K to 84.97K | |
| 14-Jan-20 7:45 PM View: | Portola Pharmaceuticals Inc (PTLA) | 14-Jan-20 | Payment of Exercise | 1,277 | $13.80 | $17,622.60 | (2%) 70.0K to 68.72K | |
| 14-Jan-20 7:45 PM View: | Portola Pharmaceuticals Inc (PTLA) | 12-Jan-20 | Grant | 2,125 | -- | -- | 3% 67.87K to 70.0K | |
| 21-May-19 8:28 PM View: | Portola Pharmaceuticals Inc (PTLA) | 20-May-19 | Payment of Exercise | 3,022 | $28.69 | $86,701.20 | (4%) 72.59K to 69.57K | |
| 21-May-19 8:28 PM View: | Portola Pharmaceuticals Inc (PTLA) | 19-May-19 | Grant | 5,859 | -- | -- | 9% 66.73K to 72.59K | |
| 08-Apr-19 7:03 PM View: | Portola Pharmaceuticals Inc (PTLA) | 04-Apr-19 | Market Sale (Planned) | 40,486 | $37.39 | $1,513,820.00 | (38%) 107.22K to 66.73K | (< 1%) |
| 05-Mar-19 6:26 PM View: | Portola Pharmaceuticals Inc (PTLA) | 04-Mar-19 | Payment of Exercise | 9,667 | $33.41 | $322,974.00 | (8%) 116.89K to 107.22K | < 1% |
| 04-Feb-19 5:47 PM View: | Portola Pharmaceuticals Inc (PTLA) | 31-Jan-19 | Grant | 18,750 | -- | -- | 19% 97.93K to 116.68K | |
| 15-Jan-19 8:14 PM View: | Portola Pharmaceuticals Inc (PTLA) | 15-Jan-19 | Payment of Exercise | 868 | $24.25 | $21,049.00 | (< 1%) 98.8K to 97.93K | (28%) |
| 15-Jan-19 8:14 PM View: | Portola Pharmaceuticals Inc (PTLA) | 12-Jan-19 | Grant | 2,125 | -- | -- | 2% 96.67K to 98.8K | |
| 05-Sep-18 7:27 PM View: | Portola Pharmaceuticals Inc (PTLA) | 04-Sep-18 | Payment of Exercise | 8,884 | $29.18 | $259,203.00 | (8%) 107.68K to 98.8K | (6%) |
| 05-Sep-18 7:27 PM View: | Portola Pharmaceuticals Inc (PTLA) | 31-Aug-18 | Option Exercise | 17,500 | -- | -- | 19% 90.18K to 107.68K | |
| 28-Aug-18 6:03 PM View: | Portola Pharmaceuticals Inc (PTLA) | 23-Aug-18 | Payment of Exercise | 8,794 | $26.05 | $229,084.00 | (8%) 116.27K to 107.48K | (19%) |
| 28-Aug-18 6:03 PM View: | Portola Pharmaceuticals Inc (PTLA) | 28-Jul-18 | Option Exercise | 17,500 | -- | -- | 18% 98.77K to 116.27K | |
| 24-May-18 8:04 PM View: | Portola Pharmaceuticals Inc (PTLA) | 22-May-18 | Grant | 5,859 | -- | -- | 5% 112.93K to 118.78K | |
| 24-May-18 8:04 PM View: | Portola Pharmaceuticals Inc (PTLA) | 22-May-18 | Payment of Exercise | 2,514 | $40.82 | $102,621.00 | (2%) 118.78K to 116.27K | 24% |
| 12-Mar-18 7:58 PM View: | Portola Pharmaceuticals Inc (PTLA) | 08-Mar-18 | Disposition | 12,474 | $38.76 | $483,531.00 | (17%) 73.92K to 61.44K | 20% |
| 06-Mar-18 5:48 PM View: | Portola Pharmaceuticals Inc (PTLA) | 02-Mar-18 | Payment of Exercise | 6,735 | $32.53 | $219,090.00 | (18%) 37.77K to 31.04K | 5% |
| 02-Feb-18 7:57 PM View: | Portola Pharmaceuticals Inc (PTLA) | 31-Jan-18 | Grant | 10,625 | -- | -- | 100% 0 to 10.63K | |
| 18-Aug-17 4:48 PM View: | Portola Pharmaceuticals Inc (PTLA) | 16-Aug-17 | Payment of Exercise | 3,635 | $54.86 | $199,416.00 | (100%) 3.63K to 0 | 44% |
| 13-Jul-17 5:54 PM View: | Portola Pharmaceuticals Inc (PTLA) | 11-Jul-17 | Option Exercise | 23,350 | $25.08 | $585,618.00 | 100% 0 to 23.35K | |
| 13-Jul-17 5:54 PM View: | Portola Pharmaceuticals Inc (PTLA) | 11-Jul-17 | Market Option Sale | 23,350 | $60.00 | $1,401,000.00 | (100%) 23.35K to 0 | 48% |
| 28-Jun-17 6:05 PM View: | Portola Pharmaceuticals Inc (PTLA) | 27-Jun-17 | Option Exercise | 93,392 | $18.59 | $1,736,010.00 | 100% 0 to 93.39K | |
| 28-Jun-17 6:05 PM View: | Portola Pharmaceuticals Inc (PTLA) | 27-Jun-17 | Market Option Sale | 93,392 | $55.46 | $5,179,820.00 | (100%) 93.39K to 0 | 44% |
| 16-Mar-17 6:45 PM View: | Portola Pharmaceuticals Inc (PTLA) | 15-Mar-17 | Option Exercise | 10,235 | $7.63 | $78,095.00 | 100% 0 to 10.23K | |
| 16-Mar-17 6:45 PM View: | Portola Pharmaceuticals Inc (PTLA) | 15-Mar-17 | Market Option Sale | 10,235 | $40.02 | $409,605.00 | (100%) 10.23K to 0 | 23% |
| 03-Mar-17 5:26 PM View: | Portola Pharmaceuticals Inc (PTLA) | 02-Mar-17 | Payment of Exercise | 5,334 | $38.61 | $205,946.00 | (10%) 56.1K to 50.77K | 20% |
| 01-Feb-17 7:57 PM View: | Portola Pharmaceuticals Inc (PTLA) | 30-Jan-17 | Grant | 15,625 | -- | -- | 100% 0 to 15.63K | |
| 01-Aug-16 8:39 PM View: | Portola Pharmaceuticals Inc (PTLA) | 01-Aug-16 | Option Exercise | 15,152 | $3.30 | $50,001.60 | 100% 0 to 15.15K | |
| 03-May-16 7:39 PM View: | Portola Pharmaceuticals Inc (PTLA) | 01-May-16 | Grant | 16,250 | -- | -- | 100% 0 to 16.25K | |
| 04-Mar-16 1:11 PM View: | Portola Pharmaceuticals Inc (PTLA) | 02-Mar-16 | Payment of Exercise | 1,524 | $31.75 | $48,387.00 | (13%) 12.0K to 10.48K | 30% |